Bharat Biotech

It has been learnt that the Drug Controller General of India (DCGI) has given emergency permission to use the vaccine "Incovac" , a drop medicine developed by Bharat Biotech, as a booster dose for the Covid-19 disease.

Bharat Biotech today announced that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.Bharat Biotech had…

The Drug Controller General of India (DCGI) on Saturday approved Covaxin for emergency use for children above 12 years. The approval is for children between 12 to 18 years of age only. The vaccine is not for children below 12 years.…

Bharat Biotech’s indigenous Covid-19 vaccine is highly efficacious, well tolerated and presents no safety concerns, a new study published in the reputed medical journal The Lancet has said.Bharat Biotech's Covaxin found to have a 77.8%…

Bharat Biotech on Monday announced that the World Health Organisation (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac 5D.